Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract PR08: Personalized therapeutic mRNA nano-vaccines are effective across multiple preclinical and translational models of head and neck cancer

Natalie L. Silver, Johnathan Chardon-Robles, Jin Dai, Rekha Garg, John Ligon, Carlos Souza, Paul Castillo, Rowan Milner, Bikash Sahay, Timothy Chan, Duane Mitchell, Elias Sayour

Clin Cancer Res (2023) 29 (18_Supplement): PR08.

https://doi.org/10.1158/1557-3265.AACRAHNS23-PR08

Published: 15 September 2023

View article titled, Abstract PR08: Personalized therapeutic mRNA nano-vaccines are effective across multiple preclinical and translational models of head and neck cancer

Journal Articles

Abstract A18: Personalized RNA nanoparticles remodel the HNSCC immunologic milieu to unlock immunotherapeutic activity

Natalie L. Silver, Rekha R. Garg, Hector R. Mendez-Gomez, Kristianna Fredenberg, Spencer Barnes, Frances L. Weidert, Peter Dziegielewski, Sayour J. Elias, Duane A. Mitchell

Clin Cancer Res (2020) 26 (12_Supplement_2): A18.

https://doi.org/10.1158/1557-3265.AACRAHNS19-A18

Published: 15 June 2020

View article titled, Abstract A18: Personalized RNA nanoparticles remodel the HNSCC immunologic milieu to unlock immunotherapeutic activity

Journal Articles

COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms

Clin Cancer Res (2019) 25 (18): 5650–5662.

https://doi.org/10.1158/1078-0432.CCR-19-0096

Published: 13 September 2019

View article titled, COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms

Includes: Multimedia, Supplementary data

Journal Articles

Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation

Clin Cancer Res (2017) 23 (21): 6541–6554.

https://doi.org/10.1158/1078-0432.CCR-17-0947

Published: 31 October 2017

View article titled, Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk <em>TP53</em> Mutation

Includes: Multimedia, Supplementary data

Journal Articles

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV⁺ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins

Noriaki Tanaka, Ameeta A. Patel, Jiping Wang, Mitchell J. Frederick, Nene N. Kalu, Mei Zhao, Alison L. Fitzgerald, Tong-xin Xie, Natalie L. Silver, Carlos Caulin, Ge Zhou, Heath D. Skinner, Faye M. Johnson, Jeffrey N. Myers, Abdullah A. Osman

Clin Cancer Res (2015) 21 (21): 4831–4844.

https://doi.org/10.1158/1078-0432.CCR-15-0279

Published: 01 November 2015

View article titled, Wee-1 Kinase Inhibition Sensitizes High-Risk HPV<sup>+</sup> HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins

Includes: Supplementary data

NARROW

Abstract PR08: Personalized therapeutic mRNA nano-vaccines are effective across multiple preclinical and translational models of head and neck cancer

Abstract A18: Personalized RNA nanoparticles remodel the HNSCC immunologic milieu to unlock immunotherapeutic activity

COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms

Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV⁺ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins

Email alerts

AACR Journals

Abstract PR08: Personalized therapeutic mRNA nano-vaccines are effective across multiple preclinical and translational models of head and neck cancer

Abstract A18: Personalized RNA nanoparticles remodel the HNSCC immunologic milieu to unlock immunotherapeutic activity

COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms

Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Wee-1 Kinase Inhibition Sensitizes High-Risk HPV⁺ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins